Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands

Dinmohamed, Avinash G.; Visser, Otto; Verhoeven, Rob H.A.; Louwman, Marieke W. J.; Nederveen, Francien H. van; Willems, Stefan M.; Merkx, M.A.W.; Lemmens, Valery; Nagtegaal, Irıs D.; Siesling, Sabine

doi:10.1016/s1470-2045(20)30265-5

Cited by 498 publications

(592 citation statements)

References 6 publications

Supporting

Mentioning

527

Contrasting

Unclassified

Order By: Relevance

“…The worries for nosocomial contagion of COVID‐19 infection are significantly limiting access to diagnostic procedures and/or clinic visits essential for cancer diagnosis. This is demonstrated by a significant reduction of cancer diagnoses in comparison with the period before the COVID‐19 outbreak, as recently reported in a recent analysis of the Netherlands Cancer Registry 11 …”

Section: Figuresupporting

confidence: 66%

Speeding tumor genotyping during the SARS‐CoV‐2 outbreak through liquid biopsy

Rolfo

Russo

Pérez

2020

Cancer

View full text Add to dashboard Cite

This commentary proposes a shift in the current diagnostic workflow for patients with metastatic cancer to incorporate the use of liquid biopsy. This proposal, born in the time of a severe crisis for the health care system, might also be applied when the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) outbreak ends and thereby reduce the turnaround time for results from molecular testing for patients with cancer and increase the number of patients potentially benefiting from highly effective targeted therapies.

show abstract

Section: Figuresupporting

confidence: 66%

Speeding tumor genotyping during the SARS‐CoV‐2 outbreak through liquid biopsy

Rolfo

Russo

Pérez

2020

Cancer

View full text Add to dashboard Cite

show abstract

“…A study from The Netherlands reported that diagnoses of cancer have dramatically decreased during the pandemic, indicating that patients cannot reach the hospitals and will be diagnosed at later stages 8 . Chen et al 5 performed a nationwide analysis of cervical cancer and concluded that the increase in the interval between diagnosis and treatment is associated with poorer prognosis among patients with cervical cancer.…”

Section: Discussionmentioning

confidence: 99%

Performing gynecologic cancer surgery during the COVID‐19 pandemic in Turkey: A multicenter retrospective observational study

Dursun¹,

Dervişoğlu

Dağgez

et al. 2020

Intl J Gynecology & Obste

View full text Add to dashboard Cite

Objective To report the perioperative outcomes of 200 patients with gynecologic cancer who underwent surgery during the Novel Coronavirus Disease (COVID‐19) pandemic and the safety of surgical approach. Methods Data of patients operated between March 10 and May 20, 2020, were collected retrospectively. Data were statistically analyzed using IBM Statistical Package for the Social Sciences (SPSS) Statistics for Windows v. SP21.0. Results Data of 200 patients were included. Their mean age was 56 years. Of the patients, 54% (n=108), 27.5% (n=55), 12.5% (n=25), and 2% (n=4) were diagnosed as having endometrial, ovarian, cervical, and vulvar cancer, respectively. Of them, 98% underwent non‐emergent surgery. A minimally invasive surgical approach was used in 18%. Stage 1 cancer was found in 68% of patients. Surgeons reported COVID‐related changes in 10% of the cases. The rate of postoperative complications was 12%. Only two patients had cough and suspected pneumonic lesions on thoracic computed tomography postoperatively, but neither was positive for COVID‐19 on polymerase chain reaction testing. Conclusion Based on the present findings, it is thought that gynecologic cancer surgery should continue during the COVID‐19 pandemic while adhering to the measures. Postponement or non‐surgical management should only be considered in patients with documented infection. Gynecologic cancer surgery should continue during the COVID‐19 pandemic while adhering to measures. Only 1% of patients developed COVID‐19‐related symptoms during the postoperative follow‐up period.

show abstract

“…to balance the risk of delaying cancer treatment with that of exposing a vulnerable patient with cancer to the virus, and this resulted in crucial reprioritization; the most essential and necessary treatments remained on schedule, whereas early preventative screenings, follow-up appointments, and nonessential surgeries were often delayed. 10 These changes were made rapidly, and the newly devised guidelines were operationalized with increased survival in mind and in hopes of rendering the oncology centers pandemic-proof. 11,12 Although taking such measures is necessary for successful infection control, the subsequent steps will have to involve consideration of the psychological impact of COVID-19 and related changes on patients with cancer, survivors, and their families.…”

Section: Introductionmentioning

confidence: 99%

The impact of COVID‐19 on the cancer care of adolescents and young adults and their well‐being: Results from an online survey conducted in the early stages of the pandemic

Košir

Loades

Wild

et al. 2020

Cancer

View full text Add to dashboard Cite

Background Because of the global spread of coronavirus disease 2019 (COVID‐19), oncology departments across the world have rapidly adapted their cancer care protocols to balance the risk of delaying cancer treatments and the risk of COVID‐19 exposure. COVID‐19 and associated changes may have an impact on the psychosocial functioning of patients with cancer and survivors. This study was designed to determine the impact of the COVID‐19 pandemic on young people living with and beyond cancer. Methods In this cross‐sectional study, 177 individuals, aged 18 to 39 years, were surveyed about the impact of COVID‐19 on their cancer care and psychological well‐being. Participants also reported their information needs with respect to COVID‐19. Responses were summarized with a content analysis approach. Results This was the first study to examine the psychological functioning of young patients and survivors during the first weeks of the COVID‐19 pandemic. A third of the respondents reported increased levels of psychological distress, and as many as 60% reported feeling more anxious than they did before COVID‐19. More than half also wanted more information tailored to them as young patients with cancer. Conclusions The COVID‐19 pandemic is rapidly evolving and changing the landscape of cancer care. Young people living with cancer are a unique population and might be more vulnerable during this time in comparison with their healthy peers. There is a need to screen for psychological distress and attend to young people whose cancer care has been delayed. As the lockdown begins to ease, the guidelines about cancer care should be updated according to this population's needs.

show abstract

Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands

Cited by 498 publications

References 6 publications

Speeding tumor genotyping during the SARS‐CoV‐2 outbreak through liquid biopsy

Speeding tumor genotyping during the SARS‐CoV‐2 outbreak through liquid biopsy

Performing gynecologic cancer surgery during the COVID‐19 pandemic in Turkey: A multicenter retrospective observational study

The impact of COVID‐19 on the cancer care of adolescents and young adults and their well‐being: Results from an online survey conducted in the early stages of the pandemic

Contact Info

Product

Resources

About